All news

SXTC revokes

Alpha Vantage · The Manila Times · · AI-summarised by FinFlash

China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) terminated the additional purchase right granted to purchasers in its registered direct offering from October 8, 2026. The right had allowed buyers to acquire up to an additional

Read original source

SXTC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.